The peer review submission system for Biomaterials is located here: http://ees.elsevier.com/biomat/

The Elsevier Editorial System (EES) is a web-based submission and review system. Authors may submit manuscripts and track their progress through the system to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Please register at: http://ees.elsevier.com/biomat/

Referees, whose names are not normally disclosed to the authors, will study all contributions which the Editor-in-Chief deems to be of sufficient significance and interest to be sent for peer review. The criteria by which this initial assessment is made include relevance to the scope of the journal, the originality of the work and its significance to the broad development of the field of biomaterials.

Before You Begin
All authors, especially those submitting to the journal for the first time, are encouraged to read the following document authored by the Editor in Chief, which gives an overview of the journal as well as the writing and selection process of academic publishing as it relates to Biomaterials: Writing Papers for Biomaterials.

Ethics in Publishing: For information on Ethics in Publishing and Ethical guidelines for journal publication see http://www.elsevier.com/authorethics and http://www.elsevier.com/ethicalguidelines.

Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

Mandatory Author Declaration: In addition to uploading manuscripts and figures, it is required that the corresponding author of each manuscript uploads a separate Author Declaration. All authors must sign this declaration; the corresponding author may not sign on behalf of other authors.

This Declaration covers a number of logistic and ethical issues. Please use the template given above for this Declaration. Authors may save this template, obtain the required signatures and then upload it as an integral part of their submission. The editorial process will not begin until and unless all authors have signed the declaration.

N.B.: The Author Declaration is independent of, and in addition to, the "Journal Publishing Agreement" agreement which is issued on acceptance.

Amendments to Manuscripts
In order to maintain the integrity of the scientific record, the version that is published in an issue on ScienceDirect and in print MUST be identical. One set of page proofs will be sent to the corresponding author. Please note that authors are urged to check their proofs carefully before return, but corrections are restricted to typesetting errors only. Proofs are NOT to be considered as drafts. No changes in, or additions to, the accepted (and subsequently edited) manuscript will be allowed at this stage. Proofreading is solely the responsibility of the corresponding author.

Copyright
All authors must sign the "Journal Publishing Agreement" before the article can be published. An e-mail (or letter) will be sent to the corresponding author confirming receipt of the manuscript together with an agreement form or a link to the online version of this agreement. This transfer agreement enables Elsevier Ltd to protect the copyrighted material for the authors, but does not relinquish the author's proprietary rights. As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.

The copyright transfer covers the exclusive rights to reproduce and distribute the article. Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.

Role of the Funding Source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.

Funding Bodies Agreements and Policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.

Open Access

This journal offers authors two choices to publish their research;

1. Open Access
• Articles are freely available to both subscribers and the wider public with permitted reuse
• An Open Access publication fee is payable by authors or their research funder2. Subscription
• Articles are made available to subscribers as well as developing countries and patient groups through our access programs (http://www.elsevier.com/access)
• No Open Access publication fee

All articles published Open Access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by your choice of one of the following Creative Commons user licenses:

Creative Commons Attribution (CC-BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Creative Commons Attribution-Non Commercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY NC SA).

Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

To provide Open Access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published Open Access.

The Open Access publication fee for this journal is $USD 3300, excluding taxes.

Learn more about Elsevier's pricing policy: http://www.elsevier.com/openaccesspricing

Manuscript Preparation

General: Manuscripts must be word processed (preferably in Word format), double-spaced with wide margins and a font size of 12 or 10 pt. Files prepared in LaTEX are not supported. Figure captions should be in Arial font 9pt. Please check the current style of the journal, particularly the reference style (Vancouver), and avoid excessive layout styling as most formatting codes will be removed or replaced during the processing of your article. In addition, do not use options such as automatic word breaking, justified layout, double columns or automatic paragraph numbering (especially for numbered references). However do use bold face, italic, subscripts, superscripts etc. The corresponding author should be identified (include a Fax number and E-mail address). Full postal addresses must be given for all co-authors. The Editors reserve the right to adjust style to certain standards of uniformity. The preferred style is: Surname, Initials, Department, Institution, City/State, Postal Code, Country. Authors should retain copies of all versions of their manuscript submitted to the journal. Authors are especially requested to be vigilant over the submission of the correct version of the manuscript at the various stages of the editorial process.

English Language: Manuscripts should be proof-read and have English language errors corrected before submission as we may have to return papers due to poor language usage. Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/languagepolishing for more information.

Paper Length: Authors are urged to write as concisely as possible.

Abstracts: All manuscripts are to be supplied with an Abstract of about 100-200 words in length.

Keywords: Authors must provide 4-6 keywords for indexing purposes. A keyword list can be found at the end of these instructions. click here).

Text: Follow this order when typing manuscripts:Title, Authors, Affiliations, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusions, Acknowledgements, References, Appendix (where necessary), Figures, Figure Captions and Tables, Supplementary Data. The corresponding author should be identified with an asterisk and footnote. All other footnotes (except for table footnotes) should be identified with superscript Arabic numbers. An abbreviated title for use as a running headline should also be supplied. Authors are requested to acknowledge funding sources for the work.

Units: The SI system should be used for all scientific and laboratory data; if, in certain instances, it is necessary to quote other units, these should be added in parentheses. Temperatures should be given in degrees Celsius. The unit 'billion' (109 in America, 1012 in Europe) is ambiguous and must not be used. If a large number of symbols are used it is helpful if authors submit a list of these symbols and their meanings.

References: All publications cited in the text should be presented in a list of references following the text of the manuscript. In the text refer to references by a number in square brackets on the line (e.g. Since Peterson[1]), and the full reference should be formatted according to the permutation of the Vancouver reference system with numbers in the text. It is suggested that authors refer to the following link for a comprehensive overview of the Vancouver reference styles: Vancouver Reference Styles

Examples of formatting follow:

1. Driessens FCM, Boltong MG, Bermudez O, Planell JA. Formulation and setting times of some calcium orthophosphate cements: a pilot study. J Mater Sci: Mater Med 1993;4:503-508.
2. Nancollas H. In vitro studies of calcium phosphate crystallisation. In: Mann S, Webb J, Williams RJP, editors. Biomineralization. Chemical and biochemical perspectives. New York: VCH, 1989. p. 157-182.
3. Brown W, Chow LC. Combinations of sparingly soluble calcium phosphates in slurries and paste as mineralizers and cements. US Patent No. 4612053, 1986.

N.B.: “Et al” must be used after the first 6 authors have been named. Biomaterials does not use the publication month or day.

Online Sources: References to online sources, including articles in press, should contain at a minimum the full URL and year the source was accessed. Furthermore, if known, the following information should be given: author names, dates, reference to a source publication.

Examples of formatting follow:

1. UK House of Commons Science and Technology Committee. Scientific Publications: Free for All? Tenth Report of Session 2003-4 Volume 1. London: The Stationary Office Ltd. Online. 2004 July. Available from URL: http://www.publications.parliament.uk/pa/cm200304/cmselect/cmsctech/399/39902.html
2. Wellcome Trust. Economic Analysis of Scientific Research Publishing. Histon, UK: Wellcome Trust. Online. 2003. Available from URL: http://www.wellcome.ac.uk/doc_wtd003181.html
3. Keeney M, Lai JH, Yang F. Recent progress in cartilage tissue engineering. Curr Opin Biotechnol. 2011. Available from URL: http://www.ncbi.nlm.nih.gov/pubmed/21531126 (DOI: 10.1016/j.copbio.2011.04.003).

Artwork

Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.

A detailed guide on electronic artwork is available on our website: http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.

Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions. Please note: Because of technical complications which can arise by converting color figures to "gray scale" (for the printed version should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.

Video Data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a maximum size of 30 MB and running time of 5 minutes. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content. Files can be stored on diskette, ZIP-disk or CD (either MS-DOS or Macintosh).

After Acceptance

Proofs: One set of page proofs in PDF format will be sent by e-mail to the corresponding author and should be returned within 48 hours of receipt. The average amount of time between acceptance and receipt of typeset proof is 6 working days. Papers are published in print within another 8 weeks upon receipt of author corrections. Corrections should be restricted to typesetting errors. Any queries should be answered in full. Please note that authors are urged to check their proofs carefully before return.

Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader© version 7 (or higher) available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win. If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.

Track a Paper: Authors can track their paper status online after the paper has been accepted and forwarded to the Publisher. Enter your Elsevier reference number (JBMT xxx) and the Corresponding author's family name at the following web page: http://www.elsevier.com/trackarticle. Corresponding authors will receive an acknowledgement email from Elsevier with the reference number and the family name on it. Authors can also go to the 'track a paper' page by clicking onto the 'track a paper' button on the left hand side of the journal home page.

Offprints: The corresponding author will be provided with a PDF of the article via email. The PDF is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms of use. Additional paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.

Author Enquiries: For enquiries relating to the submission of articles (including electronic submission where available) please visit this journal’s homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article’s status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.

Keywords">Keyword List

Back to Instructions

A
Abdomen
Abrasion
Absorption
Acid phosphatase
Acrylic acid
Acrylics
Actin
Activated charcoal
Activation energy
Adenovirus
Adhesion
Adhesion mechanism
Adhesion molecule
Adipose tissue engineering
Adsorption
AFM (atomic force microscopy)
Affinity
Age / ageing
Albumin
Alginate
Alkaline phosphatase
Allergy
Allogeneic cell
Alumina
Aluminium
Ames test
Amino acid
Aneurysm
Angiogenesis
Animal model
Anodic phenomena
Anti-adhesion
Antibacterial
Anticoagulant
Antigenicity
Antimicrobial
Antioxidant
Antisense
Apatite structure
Apolipoprotein
Apoptosis
Aragonite
Arterial structure
Arterial tissue engineering
Arthritis
Arthroplasty
Astrocyte
Audiology
Autoimmunity
Autologous cell

B
Bacteria
Bacterial adhesion
Bioabsorption
Bioactive glass
Bioactivity
Bioartificial liver
Bioartificial pancreas
Biocompatibility
Biodegradation
Bioerosion
Biofilm
Biomimetic material
Biomineralisation
Bioprosthesis
Bioreactor
Bioresorption
Biosensor
Bis-phenol A derivative
Bladder
Bladder tissue engineering
Blood
Blood compatibility
Blood flow
BMP (bone morphogenetic protein)
Bone
Bone cement
Bone graft
Bone healing
Bone ingrowth
Bone marrow
Bone regeneration
Bone remodelling
Bone repair
Bone tissue engineering
Brain
Brittleness
Brushite
Burn

C
Calcification
Calcite
Calcium
Calcium carbonate
Calcium phosphate
Calcium phosphate cement
Calcium phosphate coating
Carbon
Carcinogenesis
Cardiac rhythm
Cardiac tissue engineering
Cardiomyocyte
Cartilage
Cartilage tissue engineering
Casting
Catheter
Catheter infection
Cell activation
Cell adhesion
Cell culture
Cell encapsulation
Cell morphology
Cell proliferation
Cell signalling
Cell spreading
Cell viability
Cellulose
Ceramic structure
Chemiluminescence
Chemotaxis
Chemotherapy
Chinese herbal medicine
Chitin / chitosan
Chondrocyte
Chondroitin sulphate
Clotting
Coagulation
Cobalt alloy
Co-culture
Collagen
Collagen structure
Complement
Compliance
Composite
Compression
Computational fluid dynamics
Confocal microscopy
Connective tissue
Constitutive modelling
Contact angle
Contact lens
Contact phase activation
Controlled drug release
Copolymer
Copper
Cornea
Corrosion
Corrosion product
Coupling agent
Crack
Creep
Crevice corrosion
Cross-linking
Crystal growth
Crystallinity
Crystallisation
Crystallography
Cyclooxygenase
Cytokine
Cytotoxicity

D
Degradation
Demineralisation
Dendrimer
Dental adhesive
Dental alloy
Dental amalgam
Dental cement
Dental implant
Dental restorative material
Dentine
Dentine bonding agent
Dermis
Dextran
Diabetes
Dialysis
Diamond
Dielectric constant
DMA (dynamic mechanical analysis)
DNA
Drug delivery
Drug release
DSC (differential scanning calorimetry)
Dura

E
ECM (extracellular matrix)
Elasticity
Elastin
Elastomer
Electrical stimulation
Electroactive polymer
Electrochemistry
Electrode
Electron beam
Electron microscopy
Electronic material
Electrophysiology
ELISA
Ellipsometry
Embolisation
Endodontics
Endothelial cell
Endothelialisation
Endothelium
Endotoxin
ENT surgery
Enzyme
Epithelial cell
Epithelium
ESCA (electron spectroscopy for chemical analysis)
Esterase
Extracorporeal circulation
Extrusion

F
FACS (fluorescence activated cell sorting)
Fatigue
Ferroelectrics
Fibrin
Fibrinogen
Fibroblast
Fibroblast growth factor
Fibronectin
Fibrosis
Fibrous tissue
Finite element analysis
Flow cytometry
Fluorine - fluoride
Fluorescence
Fluorocarbon
Foreign body giant cell
Foreign body response
Fractal
Fracture mechanism
Fracture toughness
Free form fabrication
Free radical
Fretting
Friction
FTIR
Fungal infection

G
Gamma irradiation
Gelatin
Gene expression
Gene therapy
Gene transfer
Genetic engineering
Genotoxicity
Glass
Glass ceramic
Glass ionomer
Glass transition temperature
Glaucoma
Glycosaminoglycan
Gold
Growth factors

H
Haemocompatibility
Haemodialysis
Haemolysis
Haemostasis
Hair follicle
Heart
Heart assist
Heart valve
Heparin
Hepatocyte
Hip replacement prosthesis
Histomorphometry
Hyaluronic acid / hyaluronan
Hydrogel
Hydrolysis
Hydrophilicity
Hydrophobin
Hydroxyapatite
Hydroxyapatite coating
Hydroxyapatite composite
Hydroxyapatite - drug
Hydroxyethylmethacrlate
Hydroxyproline
Hypersensitivity

I
Image analysis
Immune response
Immunochemistry
Immunomodulation
Immunostimulation
In situ hybridisation
In vitro test
In vivo test
Infection
Inflammation
Infrared spectrum
Integrin
Interface
Interleukin
Intervertebral disc
Intimal hyperplasia
Intraocular lens
Intravascular stent
IPN (Interpenetrating polymer network)
Ion beam
Ion implantation
Iridium
Islet

J
Joint replacement

K
Keratin
Keratinocyte
Keratoprosthesis
Knee replacement

L
Laminin
Langmuir Blodgett film
Laser
Laser ablation
Laser manufacturing
Latex
Leukocyte
Ligament
Ligament prosthesis
Lipase
Lipid
Liposome
Liquid crystal
Liver
Liver perfusion
Lung
Lymphocyte
Lymphokine
Lysozyme

M
Macrophage
Magnesium
Magnetism
Matrix metalloproteinase
Mechanical properties
Mechanical test
Membrane
Mercury
Mesenchcymal stem cell
Metal ion
Metal ion release
Metal ion toxicity
Metal - ceramic bonding
Metal surface treatment
Metallography
Metalloproteinase
Micelle
Microbiology
Microcapsule
Microencapsulation
Micromachining
Micromotion
Micropatterning
Microsphere
Microstructure
Microwave
Middle ear
Modelling
Molecular biology
Molecular imaging
Molecular modelling
Molecular weight
Monocyte
Monomer
MRI (magnetic resonance imaging)
mRNA
MTT assay
Mucosa
Mucosal adhesion
Muscle
Mutagenicity

N
Nacre
Nanocomposite
Nanoindentation
Nanoparticle
Nanotopography
Neointima
Nerve
Nerve growth factor
Nerve guide
Nerve regeneration
Nerve tissue engineering
Neural cell
Neural network
Neural prosthesis
Neutrophil
Nickel
Nickel-titanium alloy
Nitinol
Nitric oxide
Non-woven fabric

O
Ophthalmology
Organ culture
Orthodontics
Osseointegration
Osteoblast
Osteoclast
Osteoconduction
Osteogenesis
Osteolysis
Osteopontin
Osteoporosis
Oxidation
Oxygen permeation
Oxygenation

P
Pacemaker
Palladium
Pancreas
Particulates
Passivation
Pathology
PCR (polymerase chain reaction)
Peptide
Percutaneous implant
Periodontium
Peritoneum
Phospholipid
Phosphorylcholine
Photolithography
Photopolymerisation
Photosensitisation
Phthalate
Pitting
Plasma
Plasma polymerisation
Plasma proteins
Plasma spraying
Plasminogen
Plasticisation
Plasticity
Platelet
Platelet activation
Platelet adhesion
Platinum
Pluronics
Polyacrylic acid
Polyacrylonitrile
Polyamino acid
Polyanhydride
Polycaprolactone
Polycarbonate
Polydioxanone
Polydimethylsiloxane
Polyetheretherketone
Polyethylene
Polyethylene oxide
Polyethylene terephthalate
Polyglycolic acid
PolyHEMA
Polyhydroxybutyric acid
Polylactic acid
Polymerisation
Polymethylmethacrylate
Polyorthoester
Polypropylene
Polysaccharide
Polysulphone
Polytetrafluoroethylene
Polyurethane
Polyvinylalcohol
Polyvinylchloride
Porcine tissue
Porosity
Primitive cell
Progenitor cell
Protein
Protein adsorption

R
Radiopacity
Rapid prototyping
Recombinant protein
Reproductive toxicity
Restenosis
Retina
RGD peptide

S
SBF (simulated body fluids)
Scaffold
Schwann cell
Selectin
Self assembly
SEM (scanning electron microscopy)
Shape memory
Shear
Signal transducing mediator
Silane
Silica
Silicate
Silicon
Silicon carbide
Silicon nitride
Silicone
Silicone fluid
Silicone gel
Silicone elastomer
Silk
Siloxane
Silver
SIMS (secondary ion mass spectroscopy)
SIS (small intestine submucosa)
Smooth muscle cell
Soft tissue biomechanics
Sol-gel techniques)
Spinal surgery
Stainless steel
Starch
Steel
Stem cell
Stent
Sterilisation
Strain rate
Stress analysis
Stress cracking
Sulphonated polymer
Superelasticity
Superoxide
Surface analysis
Surface energy
Surface grafting
Surface modification
Surface roughness
Surface texture
Surface topography
Surface treatment
Surgical mesh
Suture
Swelling

T
Tantalum
TEM (transmission electron microscopy)
Tendon
Tendon prosthesis
Tension
TGF (transforming growth factor)
Thermally responsive material
Thiol
Three dimensional printing
Thrombin
Thrombogenicity
Thrombomodulin
Thrombosis
Tissue adhesive
Tissue plasminogen activator
Titanium
Titanium alloy
Titanium oxide
Tracheal prosthesis
Transplantation

U
Urinary tract

V
Vascular grafts
Vinculin
Viscoelasticity
VWF (von Willibrand factor)

W
Wear debris
Wear mechanism
Wettability
Wollastonite
Wound closure
Wound dressing
Wound healing

X
Xenotransplantation
Xerogel
XRD (x-ray diffraction)
XPS (x-ray photoelectron spectroscopy)

Z
Zinc
Zirconia

Back to Instructions